Clinical Trial Update: Different Doses of IVIG for Kawasaki Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating different dosing regimens of intravenous immunoglobulin for Kawasaki disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kawasaki Disease | Phase 3 | Status: COMPLETED